1
Melkent Anthony J, Foley Kevin T: Devices and methods for receiving spinal connecting elements. Warsaw Orthopedic, Melkent Anthony J, Foley Kevin T, WILLIS Thomas L, October 18, 2007: WO/2007/118045 (80 worldwide citation)

Devices and methods include an anchor assembly (30) engageable to a vertebra and a connecting element (100) positionable through a receiver (34) of the anchor assembly (30). The receiver (34) includes chamfered surfaces (50, 70) along a leading end (46, 66) of the receiver (34) to facilitate endwise ...


2
Ying Weiwen, James David, Zhang Shijie, Przewloka Teresa, Chae Junghyun, Chimmanamada Dinesh U, Lee Chi Wan, Kostik Elena, Ng Howard P, Foley Kevin, Du Zhenjian, Barsoum James: Triazole compounds that modulate hsp90 activity. Synta Pharmaceuticals, Ying Weiwen, James David, Zhang Shijie, Przewloka Teresa, Chae Junghyun, Chimmanamada Dinesh U, Lee Chi Wan, Kostik Elena, Ng Howard P, Foley Kevin, Du Zhenjian, Barsoum James, DAVID Steven G, May 26, 2006: WO/2006/055760 (49 worldwide citation)

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, s ...


3
Foley Kevin, Bertin John, Grant Ethan P: Method for treating b cell regulated autoimmune disorders. Synta Pharmaceuticals, Foley Kevin, Bertin John, Grant Ethan P, HSI Jeffrey D, November 30, 2006: WO/2006/128172 (42 worldwide citation)

The invention relates to a method for treating B-cell regulated autoimmune disorders using compounds that modulate the activity of c-Rel.


4
Sun Lijun, Borella Christopher, Li Hao, Jiang Jun, Chen Shoujun, Koya Keizo, Inoue Takayo, Du Zhenjian, Foley Kevin, Wu Yaming, Zhang Mei, Ying Weiwen: Isoxazole combretastin derivatives for the treatment of disorders. Synta Pharmaceuticals, Sun Lijun, Borella Christopher, Li Hao, Jiang Jun, Chen Shoujun, Koya Keizo, Inoue Takayo, Du Zhenjian, Foley Kevin, Wu Yaming, Zhang Mei, Ying Weiwen, DAVIS Steven G, August 24, 2006: WO/2006/089177 (40 worldwide citation)

The invention relates to compounds of structural formula (I); or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, wherein Ra, Rb, and R2 are defined herein. These compounds inhibit tubulin polymerization and/or target vasculature and are useful for treating proliferative ...


5
Foley Kevin T, Bruneau Aurelien, Melkent Anthony J, Roehm Thomas E Iii: Posterior pedicle screw and plate system and methods. Sdgi Holdings, Foley Kevin T, Bruneau Aurelien, Melkent Anthony J, Roehm Thomas E Iii, WARMBOLD David A, September 23, 2004: WO/2004/080318 (19 worldwide citation)

An apparatus is provided for correcting spinal abnormalities, and particularly for providing compression and/or distraction of vertebrae without additional tools or instrumentation. A, plate member (20) is provided with a plurality of slots (30,32), one of which has a sloped internal edge or surface ...


6
Barsoum James, Foley Kevin: Bis(thiohydrazide amides) for inhibiting angiogenesis. Synta Pharmaceuticals, Barsoum James, Foley Kevin, DAVIS Steven G, February 28, 2008: WO/2008/024298 (15 worldwide citation)

Disclosed herein- are methods of inhibiting angiogenesis in a subject in need thereof with bis(thio-hydrazide amides) represented by a formula selected from Structural Formulas (I)- (IX) or pharmaceutically acceptable salts thereof.


7
Chae Junghyun, Demko Zachary, Ying Weiwen, Du Zhenjian, Foley Kevin, James David, Przewloka Teresa, Song Minghu, Zhang Shijie, Ng Howard P, Li Hao, Chimmanamada Dinesh U, Sun Lijun, Koya Keizo, Zhou Dan, Qin Shuzhen, Lee Chi Wan: Triazole compounds that modulate hsp90 activity. Synta Pharmaceuticals, Chae Junghyun, Demko Zachary, Ying Weiwen, Du Zhenjian, Foley Kevin, James David, Przewloka Teresa, Song Minghu, Zhang Shijie, Ng Howard P, Li Hao, Chimmanamada Dinesh U, Sun Lijun, Koya Keizo, Zhou Dan, Qin Shuzhen, Lee Chi Wan, DAVIS Steven G, December 6, 2007: WO/2007/139955 (14 worldwide citation)

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, s ...


8
Du Zhenjian, Foley Kevin: Method for treating proliferative disorders associated with protooncogene products. Synta Pharmaceuticals, Du Zhenjian, Foley Kevin, DAVIS Steven G, December 6, 2007: WO/2007/139951 (13 worldwide citation)

The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating Bcr-Abl, FLT-3, EGFR, c-Kit, B-raf, and NPM-ALK associated cancers, in a subject in need thereof.


9
Lee Chi Wan, Przewloka Teresa, Ying Weiwen, Song Minghu, Du Zhenjian, Foley Kevin, Zhou Dan, Qin Shuzhen: Triazinone and diazinone derivatives useful as hsp90 inhibitors. Synta Pharmaceuticals, Lee Chi Wan, Przewloka Teresa, Ying Weiwen, Song Minghu, Du Zhenjian, Foley Kevin, Zhou Dan, Qin Shuzhen, DAVIS Steven G, October 2, 2008: WO/2008/118391 (13 worldwide citation)

The present invention relates to compounds according to formulae (IA) to (ID) and compositions that inhibit the activity of Hsp90. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disor ...


10
Foley Kevin: Method for treating non-hodgkins lymphoma. Synta Pharmaceuticals, Foley Kevin, DAVIS Steven G, December 6, 2007: WO/2007/140002 (12 worldwide citation)

The present invention relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating non-Hodgkin's lymphoma, in a subject in need thereof.